Jpmorgan Chase & Co »

Design Therapeutics shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Design Therapeutics (DSGN) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Design Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Design Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Design Therapeutics by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $109k 41k 2.65
2023-09-30 $133k 56k 2.36
2023-06-30 $328k 52k 6.30
2023-03-31 $150k 26k 5.78
2022-12-31 $0 20k 0.00
2022-06-30 $211k 18k 11.56
2022-03-31 $326k 20k 16.12
2021-12-31 $337k 16k 21.39